CAD drug
Evidence from:
primary |
all sources
Related entities (30)
Mentioned in (10)
Papers in which this entity is mentioned.
- Integrative polygenic risk score improves the prediction accuracy of complex traits and diseases. (2024)
- Biobank-scale methods and projections for sparse polygenic prediction from machine learning. (2023)
- Frequent LPA KIV-2 Variants Lower Lipoprotein(a) Concentrations and Protect Against Coronary Artery Disease. (2021)
- Polygenic prediction via Bayesian regression and continuous shrinkage priors. (2019)
- Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. (2018)
- Genome-wide Association Study of Cannabis Dependence Severity, Novel Risk Variants, and Shared Genetic Risks. (2016)
- The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease. (2014)
- Haemolysis during sample preparation alters microRNA content of plasma. (2011)
- From child maltreatment to adolescent cannabis abuse and dependence: a developmental cascade model. (2010)
- Genetics and beyond--the transcriptome of human monocytes and disease susceptibility. (2010)
Merged raw entities (3)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| cad | phenotype | 10 | 45 |
| cad | drug | — | — |
| coronary artery disease | drug | — | — |